Qualigen Therapeutics Inc [NASDAQ: QLGN] traded at a high on Monday, posting a 2.74 gain after which it closed the day’ session at $0.10.
The results of the trading session contributed to over 6647465 shares changing hands. Over the past one week, the price volatility of Qualigen Therapeutics Inc stands at 15.68% while the volatility over the past one month is 22.30%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for QLGN stock reached $2.77 million, with 27.41 million shares outstanding and 24.81 million shares in the current float. Compared to the average trading volume of 2.80M shares, QLGN reached a trading volume of 6647465 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Qualigen Therapeutics Inc [QLGN]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for QLGN shares is $5.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on QLGN stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
How has QLGN stock performed recently?
Qualigen Therapeutics Inc [QLGN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -9.89. With this latest performance, QLGN shares dropped by -38.91% in over the last four-week period, additionally sinking by -65.48% over the last 6 months – not to mention a drop of -86.06% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for QLGN stock in for the last two-week period is set at 29.50, with the RSI for the last a single of trading hit 26.97, and the three-weeks RSI is set at 32.39 for Qualigen Therapeutics Inc [QLGN]. The present Moving Average for the last 50 days of trading for this stock 0.1604, while it was recorded at 0.1012 for the last single week of trading, and 0.2833 for the last 200 days.
Qualigen Therapeutics Inc [QLGN]: Deeper insight into the fundamentals
Qualigen Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.11 and a Current Ratio set at 0.11.
Earnings analysis for Qualigen Therapeutics Inc [QLGN]
With the latest financial reports released by the company, Qualigen Therapeutics Inc posted -1.1/share EPS, while the average EPS was predicted by analysts to be reported at -1.6/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.5. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for QLGN.
Insider trade positions for Qualigen Therapeutics Inc [QLGN]
There are presently around $1.45%, or 1.53%% of QLGN stock, in the hands of institutional investors.
